(Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in ...
Khaleej Times on MSN
US FDA approves AstraZeneca, Daiichi's breast cancer drug as first-line treatment
The US Food and Drug Administration has approved Daiichi Sankyo's therapy in combination with Roche's drug for the first-line ...
England has embraced degree apprenticeship as a solution to a wide range of challenges, including high youth unemployment, spiraling student debt and rapid technological change. The programs have been ...
Steve Eisman is a hedge-fund trader best known on Wall Street for successfully betting against the housing market before the recession of 2007-09. His experiences in the lead-up to the financial ...
Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen.
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...
Federal officials say the U.S. Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and ...
Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.
After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback